Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$9.18 - $14.15 $1.52 Million - $2.34 Million
-165,598 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$8.07 - $12.52 $587,253 - $911,080
-72,770 Reduced 30.53%
165,598 $2.07 Million
Q1 2021

May 17, 2021

BUY
$8.57 - $15.79 $1.44 Million - $2.66 Million
168,359 Added 240.48%
238,368 $2.47 Million
Q4 2020

Feb 16, 2021

BUY
$5.98 - $12.47 $418,653 - $873,012
70,009 New
70,009 $584,000
Q2 2020

Aug 14, 2020

SELL
$4.66 - $8.7 $81,358 - $151,893
-17,459 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$5.05 - $15.01 $88,167 - $262,059
17,459 New
17,459 $105,000

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $525M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.